- Entry level
- No Education
- Salary to negotiate
Position: Global Medical Affairs Leader, Faslodex
Location: Cambridge, UK
Salary: Competitive & Excellent Benefits Package
At AstraZeneca, we’re not afraid to do things differently. We’re resetting expectations of what a bio-pharmaceutical company can be. This means we’re opening up new ways to work, pioneering cutting edge methods and bringing unexpected teams together.
The Oncology therapy area at AstraZeneca is unparalleled. We have created and strategically acquired one of the most promising Oncology pipelines in the industry. You will be among inspiring oncology industry leaders who will keep you engaged and empower you to be the best. We seek out opportunities to do varied meaningful work which means we won't just follow the same course of action time and again if we can see potential in a different way of creating life changing medicine.
Global Medical Affairs (GMA) ensures the best patient outcomes by providing healthcare decision-makers around the world with the evidence and confidence they need on AstraZeneca therapies and supports our internal stakeholders with medical insight and expertise. GMA provides medical leadership with market participation and connectivity while also impacting the life cycle planning and execution of all our products. GMA aims to lead AstraZeneca in achieving scientific leadership, being a great place to work, and keeping patients at the core of everything we do.
Main Duties and Responsibilities
You will lead the medical strategy and execution of key deliverables to support the launch and lifecycle management globally for Faslodex, under the supervision of the Senior GMAL or Franchise Head.
You will provide a coordinated approach to building and sustaining Astra Zeneca’s medical leadership in breast cancer and deliver medical insight into the development and execution of a Faslodex brand strategy. You’ll oversee and support the development and execution of integrated medical plans (evidence generation and scientific communications), including global external experts, and patient centric activities.
You will be required to partner closely with colleagues in the Markets, Global Medicines Development, early research (MedImmune & IMED), Regulatory, Commercial, Access, Health Outcomes and other key functions, and help build alignment on key initiatives including optimal approach to data generation, communication and supporting access to improve patient outcomes.
You’ll also represent the brand by interfacing with internal and external stakeholders to enhance the scientific and clinical understanding of the brand.
Advanced scientific degree (M.D, PhD, PharmD) with oncology experience
Experience gained in a Senior Medical Affairs role in the pharmaceutical industry
Strong knowledge of Oncology, in particular, Breast Cancer
Understanding of drug development and commercialization processes including knowledge of outcomes research/payer access issues
Ability to generate, analyse and interpret clinical trial and published data
Track record of successfully developing and executing Medical Plans both in terms of evidence generation, scientific communications and external expert engagements
Strong project management skills with the ability to manage multiple projects and products simultaneously
Excellent communication & presentation skills
Country Launch experience
Apply now and help us change ideas in to life changing medicines!
AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law.
About the company
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines.
We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines.
We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies.
Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.